March 11, 2011 Mixing Modes of Patient-Reported Outcomes Data Collection in Clinical Trials: Recommendations
Capturing the Signal in Mild Cognitive Impairment of the Alzheimer’s Type: Industry Partnerships in Pre-Competitive Measure Development
C-Path Joins Leading Voices and Organizations in Alzheimer’s Research, Drug Discovery and Care to Call for Dramatic New Strategy to Stop Alzheimer’s Disease in Report Out Today Leaders Engaged on Alzheimer’s Disease (LEAD) was created in February 2008 as an open network of Alzheimer’s-serving o
C-Path’s Avilés Discusses Importance of Data Standards in FDA Week Article FDA is encouraging industry to use newly crafted therapeutic data standards — such as utilization of qualified biomarkers
Critical Path Institute and Clinical Data Interchange Standards Consortium Announce Release of Data Standards for Alzheimer’s Disease Research Critical Path Institute(C-Path)and Clinical Data Interchange Standards Consortium(CDISC) today announced the release of version 1.
C-Path’s K. Romero Co-Authors Special Report- Striving for an Integrated Drug-Development Process for Neurodegeneration: the Coalition Against Major Diseases Alzheimer’s and Parkinson’s diseases are the two main neurodegenerative disorders and despite the public health need,
Critical Path Institute Announces Launch of Critical Path Foundation Foundation to foster a global community of philanthropists to improve health and save lives
Pharsight to Work with Critical Path Institute’s Polycystic Kidney Disease Consortium on Disease Progression Modeling Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decisionmaking in
